Home/Orion Biotechnology/Oliver Hartley, PhD

OH

Oliver Hartley, PhD

Vice President, Drug Discovery

Orion Biotechnology

Therapeutic Areas

Obesity Metabolic Disorders

Orion Biotechnology Pipeline

Drug	Indication	Phase
GPR75 Program	Obesity	Preclinical
GIPR Program	Metabolic / Obesity	Discovery
Amylin Program	Metabolic Disorders	Discovery

Leadership Team at Orion Biotechnology

Praveen Tyle, PhD

Anatole Klepatsky, MBA

Chief Business Officer

Jarret Engstrom, MBA/PMP

Executive Director, Project & Portfolio Management

Erik Heegard, MD/PhD

Medical Director

Jim McGuire, PhD

Director of Pharmacology

View full Orion Biotechnology profile